Crohn’s is a condition that affects one in 800 people in the UK and causes chronic intestinal inflammation, leading to pain, bleeding and diarrhoea.

The team found that a bacterium called Mycobacterium paratuberculosis releases a molecule that prevents a type of white blood cell from killing E.coli bacteria found in the body. E.coli is known to be present within Crohn’s disease tissue in increased numbers.

It is thought that the Mycobacteria make their way into the body’s system via cows’ milk and other dairy products. In cattle it can cause an illness called Johne's disease - a wasting, diarrhoeal condition. Until now, however, it has been unclear how this bacterium could trigger intestinal inflammation in humans.

CHESHIRE, Connecticut, December 10 /PRNewswire/ --

- Study Shows that Long-Term Soliris Therapy Continued to Be Associated with Reductions in Thrombosis and Improvements in Fatigue, Quality of Life, and Anemia in PNH Patients

- Data Presented at the American Society of Hematology (ASH) Annual Meeting

Posters: 897-III & 891-III

Researchers discovered genetic evidence that human evolution is speeding up – and has not halted or proceeded at a constant rate, as had been thought – indicating that humans on different continents are becoming increasingly different.

“We used a new genomic technology to show that humans are evolving rapidly, and that the pace of change has accelerated a lot in the last 40,000 years, especially since the end of the Ice Age roughly 10,000 years ago,” says research team leader Henry Harpending, a distinguished professor of anthropology at the University of Utah.

Harpending says there are provocative implications from the study, published Dec. 10 in the journal Proceedings of the National Academy of Sciences:

BRISTOL, England, December 10 /PRNewswire/ --

- The Creators of 'PaRappa the Rapper' Return With Music-Based Video Game

Majesco Entertainment Company (NASDAQ: COOL), an innovative provider of video games for the mass market, today announced a partnership with legendary multimedia musician and game designer, Masaya Matsuura, and famed New York artist Rodney Alan Greenblat, to develop and publish an original music-based video game scheduled for release in late 2008. Creators of the highly acclaimed, best-selling PaRappa the Rapper series, Matsuura and Greenblat will bring their engaging gameplay and distinctive art style to the Wii(TM) home video game system for the first time.

HALIFAX, Canada, December 10 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a Nova Scotia-based vaccine enhancement company, has signed a binding memorandum of understanding to acquire Immunotope Inc., a Pennsylvania-based biotechnology company developing immunotherapy products for the treatment and prevention of cancer and infectious diseases.

CALGARY, Canada, December 10 /PRNewswire/ --

- New Class of ApoA-I/HDL Drugs to Reverse Atherosclerosis Enters the Clinic

Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that it has received approval by the US Food and Drug Administration (FDA) to initiate a Phase 1a clinical trial of oral RVX-208 in the USA. RVX-208 is a novel first-in-class small molecule that increases the production of ApoA-I and HDL. ApoA-I is regarded as the critical cardioprotective protein for the treatment of cardiovascular diseases.

AMSTERDAM, December 10 /PRNewswire/ -- BMEYE(TM) announced today that it has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) to market Nexfin(TM), their newly developed line of safe, precise and easy to use hemodynamic monitors. The Nexfin(TM) monitors provide precise and easy to use continuous non-invasive blood pressure and cardiac output monitoring. BMEYE(TM) received CE market approval earlier this year.

MILPITAS, California, December 10 /PRNewswire/ --

SAN MATEO, California, December 10 /PRNewswire/ --

NetSuite Inc. today announced that the auction for its proposed initial public offering of its common stock has commenced. NetSuite announced that it expects the offering to price after the stock market closes on or about Wednesday, December 19, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20021024/SFTH024LOGO)

Credit Suisse Securities (USA) LLC will act as sole book-running manager for the offering, with W.R. Hambrecht + Co., LLC acting as co-manager. NetSuite will offer 6,200,000 shares of its common stock in the offering. NetSuite and the selling stockholders have also granted the underwriters a 30-day option to purchase up to an aggregate of 930,000 additional shares.

SAN JOSE, California, December 10 /PRNewswire/ --

- In its Latest Web Security Trends Report, Finjan Explores "Trojan 2.0" Attacks That Utilize Regular Web 2.0 Technology to Exploit Legitimate Web Services